References
- SusmanGMasonJComptonDStewartJRicardNThe efficacy and safety of fexofenadine HCl and pseudoephedrine, alone and in combination, in seasonal allergic rhinitisJ Allergy Clin Immunol199910410010610400846
- PiaoHMBalakrishnanPChoHJPreparation and evaluation of fexofenadine microemulsions for intranasal deliveryInt J Pharm201039530931620635476
- JohnHKAllergic rhinitis: current pharmacotherapyOtolaryngol Clin North Am20084134735818328373
- MarkhamAWagstaffAJFexofenadineDrugs1998552692769506246
- UjieKOdaMKobayashiMSaitohHRelative contribution of absorptive and secretory transporters to the intestinal absorption of fexofenadine in ratsInt J Pharm200836171118572335
- GarteizDAHookRHWalkerBJOkerholmRAPharmacokinetics and biotransformation studies of terfenadine in manArzneimittelforschung198232118511906817765
- KoganAKesselmanEDaninoDAserinAGartiNViability and permeability across Caco-2 cells of carbamazepine solubilized in fully dilutable microemulsionsColloids Surf B Biointerfaces20086611218599273
- ShimizuMUnoTSugawaraKTateishiTEffects of itraconazole and diltiazem on the pharmacokinetics of fexofenadine, a substrate of P-glycoproteinBr J Clin Pharmacol20066153854416669847
- ChenCSome pharmacokinetic aspects of the lipophilic terfenadine and zwitterionic fexofenadine in humansDrugs R D2007830131417767395
- DrescherSSchaeffelerEHitzlMMDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadineBr J Clin Pharmacol20025352653411994059
- ShimizuTUnoKSugawaraKTateishiTEffects of itraconazole and diltiazem on the pharmacokinetics of fexofenadine, a substrate of P-glycoproteinBr J Clin Pharmacol20066153854416669847
- RitschelWAMicroemulsions for improved peptide absorption from the gastrointestinal tractMethods Find Exp Clin Pharmacol1991132052202051845
- SarciauxJMAcarLSadoPAUsing microemulsion formulations for oral delivery of therapeutic peptidesInt J Pharm1995120127136
- GaoZChoiHGShinHJPhysicochemical characterization and evaluation of a microemulsion system for oral delivery of cyclosporin AInt J Pharm19981617586
- EcclestonGMMicroemulsionsswarbrickSBoylanJCEncyclopedia of Pharmaceutical TechnologyNew York, NYmarcel Dekker1992
- ConstantinidesPPLipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspectsPharm Res199512156115728592652
- LinHGebhardtMBianSEnhancing effect of surfactants on fexofenadine-HCl transport across the human nasal epithelial cell monolayerInt J Pharm2007330233116997520
- JadhavKRShaikhIMAmbadeKWKadamVJApplications of microemulsion based drug delivery systemCurr Drug Deliv2006326727316848728
- YinYMCuiFDMuCFDocetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluationJ Control Release2009140869419709639
- KarakuşSKüçükgüzelIKüçükgüzelGSDevelopment and validation of a rapid RP-HPLC method for the determination of cetirizine or fexofenadine with pseudoephedrine in binary pharmaceutical dosage formsJ Pharm Biomed Anal20084629530218054459
- GhoshPKMajithiyaRJUmrethiaMLMurthyRSDesign and development of microemulsion drug delivery system of acyclovir for improvement of oral bioavailabilityAAPS Pharm Sci Tech2006777
- CuiJYuBZhaoYEnhancement of oral absorption of curcumin by self-microemulsifying drug delivery systemsInt J Pharm200937114815519124065
- Gonzalez-AlvarezIGonzalez-AlvarezMOltra-NogueraDUnique pharmacology of KAR–2, a potential anti-cancer agent: absorption modeling and selective mitotic spindle targetingEur J Pharm Sci200836911
- GolightlyLKGreosLSSecond-generation antihistamines: actions and efficacy in the management of allergic disordersDrugs20056534138415669879
- PengSXRitchieDMCousineauMDanserEDewireRFlodenJAltered oral bioavailability and pharmacokinetics of P-glycoprotein substrates by coadministration of biochanin AJ Pharm Sci2006951984199316850393
- OgasawaraAKumeTKazamaEEffect of oral ketoconazole on intestinal first-pass effect of midazolam and fexofenadine in cynomolgus monkeysDrug Metab Dispos20073541041817142564
- LiYZhangMWangJZhangSLiuJZhangQEffects of absorption enhancers on intestinal absorption of lumbrokinaseYao Xue Xue Bao200641939944 Chinese17184110
- YamamotoAUchiyamaTNishikawaRFujitaTMuranishiSEffectiveness and toxicity screening of various absorption enhancers in the rat small intestine: effects of absorption enhancers on the intestinal absorption of phenol red and the release of protein and phospholipids from the intestinal membraneJ Pharm Pharmacol199648128512899004192
- AlanyRGRadesTAgatonovic-KustrinSDaviesNMTuckerIGEffects of alcohols and diols on the phase behaviour of quaternary systemsInt J Pharm200019614114510699705
- PodlogarFGasperlinMTomsicMJamnikARogacMBStructural characterisation of water-Tween 40/Imwitor 308-isopropyl myristate microemulsions using different experimental methodsInt J Pharm200427611512815113620
- LangguthPBohnerVHeizmannJThe challenge of proteolytic enzymes in intestinal peptide deliveryJ Control Release1997463957
- LappinGShishikuraYJochemsenRPharmacokinetics of fexofenadine: evaluation of a microdose and assessment of absolute oral bioavailabilityEur J Pharm Sci20104012513120307657
- KumarLAlamMSMeenaCLJainRBansalAKFexofenadine hydrochlorideProfiles of Drug Substances, Excipients and Related Methodology200934153192